| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |